key: cord-0325842-s42ws2eu authors: Wang, Y.; Liang, X.; Jiang, Y.; Dong, D.; Zhang, C.; Song, T.; Chen, M.; You, Y.; Liu, H.; Ge, M.; Dai, H.; Xi, F.; Zhou, W.; Chen, J.-Q.; Wang, Q.; Chen, Q.; Yu, W. title: Species-specific bacterial detector for fast pathogen diagnosis of severe pneumonia patients in the intensive care unit date: 2022-03-25 journal: nan DOI: 10.1101/2022.03.25.22272920 sha: 6a34fe3f439dc3c116c4b366a43e52e5b249950a doc_id: 325842 cord_uid: s42ws2eu Rapid diagnosis of pathogens is the cornerstone of appropriate therapy and is also a great challenge to be overcome. Although NGS and some other PCR-based pathogen detection methods were applied to improve the speed and accuracy of clinical diagnosis, it was still a long way from the clinical needs of rapid and accurate diagnostic therapy in the intensive care unit (ICU). In this study, we aimed at developing a new rapid diagnostic tool, Species-Specific Bacterial Detector (SSBD), to evaluate the existence and quantification of 10 most usual pathogenic bacteria in ICU in 4 hours. Briefly, the species-specific genome fragments of each bacterium were identified by our algorithm using 1791 microbe genomes from 232 species and then used to combine with CRISPR/Cas12 to establish diagnosis tools. Based on the tests of 77 samples, SSBD demonstrated 100% sensitivity and 87% specificity compared with conventional culture test (CCT). Later on, an interventional random-grouped study was applied to evaluate the clinical benefits of SSBD. Briefly, SSBD demonstrated more accurate and faster diagnosis results and led to earlier antibiotics adjustment than CCT. Based on the results acquired by SSBD, cultivation results could deviate from the real pathogenic situation with polymicrobial infections. In addition, nosocomial infections were found widely in ICU, which should deserve more attention. Sepsis is associated with high morbidity and mortality [1] . Adequate antibiotic therapy 68 in time could decrease mortality and reduce the length of stay in ICU for patients with 69 sepsis or septic shock [2] [3] [4] [5] . As reported in the previous study, the mortality rate of 70 patients increased approximately 7.6% for every hour delayed [3] . Therefore, rapid 71 diagnosis of pathogenic microorganisms is crucial for shortening the time of empirical 72 antibiotic therapy and improving the prognosis of patients with sepsis. 73 Conventional culture test (CCT) is the most commonly used and golden standard 74 identification method of pathogenic microorganisms in most countries. However, it 75 showed two critical limitations: long time-consuming (2 to 5 days) and low sensitivity 76 (30-50%), which limited the application of this method in the ICU [6, 7] . To overcome 77 this bottleneck, several new tools were developed and showed significant improvement 78 in time consumption and accuracy. Recently, next-generation sequencing (NGS) 79 technology was applied to acquire the entire information of microorganisms and 80 demonstrated great ability in diagnosing rare pathogens. However, the whole process 81 still needs at least 2 days for the full diagnostic report with high cost [8, 9] . On the other 82 hand, NGS provided too much information about microorganisms but only semi-83 quantification of pathogens, which was hard for most clinical doctors to extract the most 84 important information to determine antibiotic usage. Other new emerging detection 85 techniques designed by BioFire and Curetis are much superior in detection time than 86 these above. However, its original principle was based on nucleotide diversity of 87 conserved genes among species, which could not satisfy the application in the ICU due species (S1 and S2 Table) . To evaluate our primers' specificity in identifying species, we chose S. aureus and S. 134 epidermidis from the same genus as our cross-validated target species. We extracted Patients admitted to ICUs and diagnosed with severe pneumonia were recruited from 145 Aug 27, 2019. The recruit criteria for patients were: (1) age ≥ 18 years; (2) had artificial 146 airway and expected to retain for more than 48 hours; (3) clinically diagnosed as 147 pneumonia, and the microbiology of etiology was unclear; (4) signed informed consent; 148 (5) the expected length of staying in ICU was more than 3 days. According to previous 149 mortality acquired from the adequate anti-infective group, the sample size calculation 150 (two-group rate) for patients was done, and a sample size of 73 patients in each group 151 was needed. BALFs were obtained from all the patients from 2 groups on day 1, day 3-5, and day 7-154 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The first step to identify pathogenic bacteria was to figure out the specific genome 180 information of each species. Unlike viruses or animals, bacteria were quite similar 181 between close-related species but sometimes quite different among different strains of 182 one species due to fast evolution and horizontal gene transfer [13] [14] [15] . Therefore, the 183 widely-used method to identify bacteria with conserved genes may not be a good choice 184 [16, 17] . We developed an innovative algorithm and designed a workflow to figure out 185 the best DNA tag for each species for diagnostic application based on 1791 microbe 186 genomes from 232 species (Fig 2A) . The details could be found in the Supplementary 187 Materials. 188 We started from 10 common bacteria contributing to sepsis infection as the initial [18, 19] . To our surprise, bacteria-specific 191 DNA sequences showed a random distribution and turned out to be only 0. 3%-4.1% in 192 the whole genomes of 10 bacteria (Fig 2B and 2C) . Considering the application 193 scenario of ICU with only basic instruments, PCR+CRISPR/Cas12a system was chosen 194 for the following detection. Based on the identified species-specific DNA fragments, 195 related primers and crRNAs (CRISPR RNA) were designed according to each species 196 (S1 and S2 Table) . perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in To optimize the working conditions of the detection tool in ICU, multiple 202 experiments were applied to optimize the sample preparation and detection process. With the gradient concentration of DNA templates, we confirmed that the lowest 204 detection limit was 10 -15 M with PCR amplification and 10 -8 M without amplification 205 step (Fig 3B) , which was consistent with previous studies [21] . In addition, 30 minutes' 206 incubation of CRISPR/Cas12a with PCR products was enough to demonstrate signals 207 (Fig 3B) . An additional purification step right after PCR amplification appeared confirm the specificity of SSBD, each bacteria strain was tested by 10 SSBD test panels 216 targeting different bacteria. Compared to negative control, only SSBD targeting the 217 tested bacteria showed a positive result, which confirmed its high specificity (Fig 3C) . 218 Putting these results together, a standard operating procedure was finally established 219 for the following validation stages (Fig 3A) , which was capable of providing the 220 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 25, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 information about the ten most common pathogenic bacteria in ICU. Since this method 221 was a quite fast and species-specific bacteria detection tool, we named it SSBD. 223 We started our study with validation stage I, which was a non-intervention study with 224 77 samples of BALF extracted from patients. Samples were detected both by SSBD 225 and CCT, and the results were compared (raw detection results were shown in S3 Table) . 226 Generally, 5 of 10 selected bacteria were detected by both tests, including A. baumannii, 227 K. pneumoniae, P. aeruginosa, S. aureus and S. maltophilia. SSBD could detect those 228 5 bacteria separately with 100% sensitivity and over 87% specificity, which were 229 calculated by the results of CCT as golden standard (Fig 4A) . The other 5 bacteria were 230 detected by SSBD but not CCT, including E. coli, S. epidermidis, S. capitis, E. faecalis 231 and E. faecium. To further evaluate the results, 11 samples among all 77 samples were 232 collected randomly and sent for NGS detection, which confirmed that SSBD and NGS 233 demonstrated quite high similarities in results (Fig 4A) . 234 Based on these accurate results, we started the validation stage II, which was an 235 intervention study aiming to evaluate the clinical benefits of SSBD compared to the 236 current diagnosis and treatment strategy in ICU. Although the study was paused due to 237 the outbreak of SARS-CoV2, 22 patients were recruited into the experiment group and 238 24 patients into the control group. The baseline characteristics had no significant 239 difference except ages (S5 Table) . 240 We finally got 57 BALF results tested by SSBD, which included 43 results that also 241 had CCT results among them in the experiment group. While in the control group, we 242 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in bacterium with similar high sensitivity and specificity in validation stage II (Fig 4B) . 247 Consistent with the local epidemic data, the most frequent occurrence was A. baumannii 248 (Fig 4B) . 12 of the 57 samples were also sent for the NGS technology, and the SSBD 249 also showed high consistency between those two methods compared to CCT (Fig 4B) . 250 To explore clinical benefits with the help of SSBD, effective antibiotic coverage rate, 251 APACHE II scores and SOFA scores were calculated and compared to evaluate the 252 rationalization of antibiotic therapy and patients' disease severity and organ function 253 status in the two groups (Fig 4C-4E) . Effective antibiotic coverage rates for each test 254 were significantly higher in the experimental group than those in the control group in 255 three tests (Fig 4C) . The definition of antibiotic coverage and the original calculation 256 results were shown in S4A-B Fig. APACHE II scores were significantly lower in the 257 experimental group than those in the control group after day 1 (p=0.0035, two-way 258 ANOVA); the separation between two groups of patients increased progressively until 259 day 14 (Fig 4D) . SOFA scores showed no difference between the groups (p=0.8918, 260 two-way ANOVA) (Fig 4E) . Other clinical outcomes showed no significant difference 261 in both groups, such as time of ventilation, shock, 28-day mortality and the numbers of 262 antibiotic-associated diarrhea (S6 Table) . 264 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Here, we defined situations of infection with more than one pathogenic microorganism 268 as polymicrobial infection events to assess the performance based on the results of both 269 methods. From the results, the detection rate of polymicrobial infection events by SSBD 270 was 41.8% (55/134) in two validation stages, which was significantly higher than 11.7% 271 (14/120) of CCT (Fig 5A) . To confirmed the reliability of the extra detected 272 polymicrobial infection events by SSBD, 6 samples were sent for NGS, which 273 demonstrated the same results as SSBD (Fig 5B) . 274 Since both SSBD and NGS were based on target DNA, we wanted to confirm if some 275 polymicrobial infection events were "false positive" and caused by dead bacteria. Here, 276 we showed patient B19 as an example, who received three times tests at day 1, 3 and 7 277 by both CCT and SSBD. Based on the results, S. maltophilia was detected as level II in 278 test1 with SSBD but not CCT. Later on, S. maltophilia was detected by CCT in test2 as 279 well with few days' development from level II to level III based on result of SSBD, 280 which means SSBD discovered the true polymicrobial infection event earlier than CCT 281 (Fig 5C) . From the aspect of pathogen species participated in polymicrobial infection 282 events, both methods demonstrated similar results with A. baumannii, S. maltophilia, P. 283 aeruginosa, K. pneumoniae and S. aureus in top 5 (Fig 5D) , which were consistent with 284 the frequency of pathogens in ICU [18] . Hospital infections, also known as nosocomial infections, are an important factor in 286 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in for SSBD and CCT (Fig 5E and 5F ). Based on the results of SSBD, 47.6% (10/21) of 294 patients had nosocomial infections at the test 2, and 28.6% (4/14) of patients had 295 nosocomial infections at the test 3. Similarly, 40% (4/10) of patients were identified as 296 nosocomial infections by CCT at test 2, and 27.3% (3/11) of patients were identified as 297 nosocomial infections at test 3 (Fig 5G) . perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 25, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 rpoB; E-value=8e-39, gyrB), which could interfere with pathogen identification 309 between species from the same genus. It was ideal for early and rapid screening of perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 25, 2022. ; https://doi.org/10.1101/2022.03.25.22272920 doi: medRxiv preprint antibiotic therapy strategy. CRISPR/Cas12a and qPCR are both quantitative methods, 331 but CRISPR/Cas12a shows its robustness and lower equipment requirement, which 332 satisfied our needs for most of the ICU. There are still several challenges in 333 implementing POCT in developing countries, especially the qPCR/POCT system, 334 which will be an alternative. The results of SSBD demonstrated high sensitivity and specificity. However, we 336 discovered several "false positive" results compared to CCT, which might be caused by patients were infected by more than one pathogen, which might cause potential 351 competition between different pathogens in CCT process (S7 Table) . For example, A. 2) The 10 designed pathogens were originated from sepsis, which might not completely As anticipated, SSBD performed well with high sensitivity and specificity in rapid 391 pathogens identification, and it reduced TTAT, which was associated with more rapid 392 administration of appropriate antimicrobial therapy in the experiment cases. SSBD also 393 has enormous potential in expanding pathogens from different diseases with much more 394 pathogen genomes concluded. We believe that SSBD is competent in the role of clinical 395 application and able to be applied in more clinical research. 396 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 25, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 25, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 25, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 Supplementary Figure 1 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 25, 2022. ; https://doi.org/10.1101/2022.03.25.22272920 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 25, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 The impact of horizontal gene transfer on 442 targeting the internal transcribed spacer region (ITS) to identify Acinetobacter junii strains A paradigm shift in our view of species drives current 445 trends in biological classification Severe pneumonia in intensive care: 447 cause, diagnosis, treatment and management: a review of the literature. Current Opinion 448 in Pulmonary Medicine Sepsis in Intensive Care Unit Patients Worldwide Data From the Intensive Care over Nations Audit CRISPR-Cas12a target binding unleashes indiscriminate single-455 stranded DNase activity Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, 458 and Csm6 Impact of 460 polymicrobial biofilms in catheterassociated urinary tract infections Update of the 465 treatment of nosocomial pneumonia in the ICU Risk Factors and Molecular 467 Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem Enterobacteriaceae: A Multicenter Study in China Against Enterobacteriaceae Isolates Obtained from Intra-472 abdominal, Respiratory Tract, and Urinary Tract Infections in China: Study for Monitoring 473 Antimicrobial photodynamic therapy fighting 477 polymicrobial infections -a journey from in vitro to in vivo. Photochemical & 478 Photobiological Sciences The social life of microbes in chronic infection 2%) others (<=1%)